Sanofi in talks to sell generics arm to Advent for $2.4 billion: Reuters

French healthcare group Sanofi (SASY.PA) is in exclusive talks to sell its Zentiva European generics drugs arm to private equity firm Advent International for 1.9 billion euros ($2.4 billion), the companies said on Tuesday.